Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 60%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 55% · prior close shown (market closed)
Limited proprietary earnings coverage for SMMT yet — signals will sharpen as filings and earnings are ingested.
Pipeline evidence · 34d ago
Reported figures for Summit Therapeutics Inc. — research only, not investment advice.
Updated
What happened recently for Summit Therapeutics Inc. (SMMT) — events, not interpretation.
Research & analysis only — not investment advice.
Investment snapshot
Prior close
$14.00
Market cap
$11.17B
Profitable
No
Net income
$-1.08B
FY Dec 31, 2025
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
US equity research on AlphaOS
Investment Snapshot above is the primary AlphaOS analysis for Summit Therapeutics Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected companies and research pages from the AlphaOS knowledge graph.
Follow Summit Therapeutics Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.